ICAS
BSX icon

Investors Capital Advisory Services’s Boston Scientific BSX Stock Holding History

Investors Capital Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,879
Closed -$129K – 679
2013
Q4 		$129K Sell
10,879
-2,140
-16% -$25.3K 0.03% 556
2013
Q3 		$151K Sell
13,019
-1,825
-12% -$19.7K 0.04% 501
2013
Q2 		$136K Buy
+14,844
New +$126K 0.04% 460

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Investors Capital Advisory Services's BSX Position: Q1 2014 in Review

Investors Capital Advisory Services sold out of Boston Scientific (BSX) in Q1 2014, closing a stake of 10,879 shares — an estimated $129K sold.

Investors Capital Advisory Services first reported a position in BSX in Q2 2013 and held it in 3 quarters. The position peaked at $151K in Q3 2013. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.

  • Investors Capital Advisory Services reported no remaining Boston Scientific position as of Q1 2014 after selling out during the quarter.
  • Investors Capital Advisory Services sold 10,879 Boston Scientific shares in Q1 2014, an estimated $129K.
  • Investors Capital Advisory Services first reported a position in Boston Scientific in Q2 2013 and held it in 3 quarters.
  • Investors Capital Advisory Services's Boston Scientific position peaked at $151K in Q3 2013.
  • 440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.

Based on Investors Capital Advisory Services's 13F filing for Q1 2014, filed 15 Apr 2014.